HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert Blackie Selected Research

N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugate

6/2009Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert Blackie Research Topics

Disease

1Breast Cancer 3
06/2009
1Breast Neoplasms (Breast Cancer)
06/2009
1Neoplasms (Cancer)
06/2009
1Colorectal Neoplasms (Colorectal Cancer)
06/2009

Drug/Important Bio-Agent (IBA)

1N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugateIBA
06/2009
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2009
1PolymersIBA
06/2009
1AnthracyclinesIBA
06/2009

Therapy/Procedure

1Therapeutics
06/2009